<DOC>
	<DOCNO>NCT01714180</DOCNO>
	<brief_summary>Studies show different percentage body fat alter way drug distribute body . This study use blood sample take different time point patient take acyclovir determine high body weight affect drug exposure . The information gather study help understand patient high body weight need different dosing plan . Patients receive acyclovir standard care enrol study . They blood draw take acyclovir 10 time take acyclovir ( total 12 hour ) . These patient hospital already need make additional trip back blood drawn . A total 4—5 tablespoon blood drawn study . 7 obese patient 7 match , non—obese patient enrol study .</brief_summary>
	<brief_title>Effect Body Mass Acyclovir Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Age ≥18 year age Receiving intravenous acyclovir 5 mg/kg ( total body weight [ TBW ] normal weight patient ideal body weight [ IBW ] obese patient ) part routine care Admitted inpatient expect stay least 24 hour Weight &gt; 190 % ideal body weight ( IBW ) `` obese '' patient weight 80120 % IBW match control patient . Receipt acyclovir similar agent ( valacyclovir , ganciclovir , valganciclovir , famciclovir ) prior 24 hour Serum creatinine &gt; 1.5 mg/dL time drug administration Hypersensitivity acyclovir Patients require ventilator support vasopressor prior 24 hour Receipt probenecid , mycophenolate , tenofovir , zidovudine prior 7 day Pregnant breastfeed Significant anatomical deformity influence body habitus ( i.e . amputation ) Prior inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Acyclovir</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Obese</keyword>
	<keyword>Non-obese</keyword>
	<keyword>Weight</keyword>
	<keyword>Distribution</keyword>
	<keyword>Clearance</keyword>
</DOC>